Subclinical hypothyroidism and cardiovascular risk: how to end the controversy.
暂无分享,去创建一个
[1] J. Manson,et al. Subclinical hypothyroidism and risk for incident myocardial infarction among postmenopausal women. , 2013, The Journal of clinical endocrinology and metabolism.
[2] A. Arnold,et al. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. , 2013, The Journal of clinical endocrinology and metabolism.
[3] E. Vittinghoff,et al. Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events: An Individual Participant Data Analysis From 6 Prospective Cohorts , 2012, Circulation.
[4] N. Rodondi,et al. Subclinical thyroid disorders , 2012, The Lancet.
[5] J. Franklyn,et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. , 2010, JAMA.
[6] M. Vanderpump,et al. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. , 2008, The Journal of clinical endocrinology and metabolism.
[7] D. Bauer,et al. Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality , 2008, Annals of Internal Medicine.
[8] B. Biondi,et al. The clinical significance of subclinical thyroid dysfunction. , 2008, Endocrine reviews.
[9] J. Weaver,et al. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. , 2007, The Journal of clinical endocrinology and metabolism.
[10] E. Mazzaferri. Subclinical Hypothyroidism and the Risk of Coronary Heart Disease: A Meta-Analysis , 2007 .
[11] E. Mazzaferri. Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults , 2007 .
[12] E. Vittinghoff,et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. , 2005, Archives of internal medicine.
[13] Mark C Simmonds,et al. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice , 2005, Clinical trials.
[14] C. Palombo,et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. , 2004, The Journal of clinical endocrinology and metabolism.
[15] M. Helfand. Screening for Subclinical Thyroid Dysfunction in Nonpregnant Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force , 2004, Annals of Internal Medicine.
[16] J. Franklyn,et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.
[17] H. Gharib,et al. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[18] D. Vanness,et al. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L). , 2003, Mayo Clinic proceedings.
[19] A. Hofman,et al. Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.